Your Messages Inbox
Your Article Summary
See Latest ArticlesSpecialty Laboratories Launches First Genomic Clinical Laboratory Test to Predict Progression to Liver Fibrosis for Hepatitis C Virus Patients
Corporate News Releases - The Healthcare Sales & Marketing Network, 10/06/06
Specialty Laboratories announced the launch of HCV Liver Fibrosis GenotypR(TM), the first genomic clinical test to predict progression to liver fibrosis or cirrhosis for hepatitis C virus patients. This test identifies the patient's genomic signature of seven single nucleotide polymorphisms to provide a Cirrhosis Risk Score (CRS) which rates the relative risk of progression to liver fibrosis or cirrhosis
Today in Medical Devices/Products...keeping you current
Receive free subspecialty "5-minute updates" via email
New Amgen Scholars Web site Launches to Build a Global Network for Future Scientists
Amgen, 12/04/09
Genzyme Begins Shipping Newly Produced Cerezyme from Allston Plant
Genzyme, 12/02/09
Bayer's Betaferon approved in China for Treatment of Multiple Sclerosis
BayNews International, 12/02/09
Article Search
Sponsor